Clinical trial Recruiting at 11 sites Phase 4 Interventional Ages 21 and up Men only

Daily tadalafil plus as-needed sildenafil for men whose ED did not respond to PDE5 inhibitors

Official title: Daily Tadalafil 5 mg Combined With On-Demand Sildenafil 100 mg for Treatment of Erectile Dysfunction in PDE-5I Non Responder Patients: A Multicenter Randomized, Double-Blind, Placebo-Controlled Trial

Run by Mansoura University · NCT07391579 · Data updated 2026-11-12

This tests whether taking tadalafil 5 mg every day together with sildenafil 100 mg as needed helps men with erectile dysfunction who did not respond to PDE5 inhibitors alone.

More Erectile Dysfunctions trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages21 Years and up
SexMen only
Enrollment500 (estimated)
SponsorMansoura University
Academic / other
Drugs / interventionsradiation
Locations11 sites (Al Mansurah, Dakahlia Governorate and 10 other locations)
StatusRecruiting
StartedDecember 1, 2025
Main results expectedDecember 2026
Study endsJune 2027
Registry record updatedFebruary 6, 2026
Trial IDNCT07391579 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Sexually active adult men with ED for ≥6 months, IIEF-EF score <17, documented non-response to maximum-dose PDE5 inhibitors on at least four occasions, and a stable sexual relationship of ≥6 months are the intended participants.

Probably not a fit

Men with penile anatomical deformities or prior penile surgery, active malignancy or severe systemic illness, contraindications to PDE5 inhibitors (including nitrate use or high cardiac risk), or current alternative ED treatments are excluded and unlikely to benefit from this regimen.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This phase 4, randomized interventional study enrolls men with at least six months of erectile dysfunction who failed to respond to maximum-dose PDE5 inhibitors. Participants are randomly assigned to daily tadalafil 5 mg plus on-demand sildenafil 100 mg or daily placebo plus on-demand sildenafil 100 mg, with baseline exams and lab testing before treatment. The main efficacy outcome is change in erectile function measured by the IIEF-EF domain, and safety/tolerability are monitored throughout. The trial is conducted at multiple university urology centers in Egypt.

Why it matters

Potential benefit: If successful, the combination could restore erectile function and improve sexual satisfaction for men who previously did not respond to PDE5 inhibitors alone.

How similar studies have gone: Smaller clinical reports and clinical experience suggest switching or combining PDE5 inhibitors can help some non-responders, but large randomized evidence is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Sexually active male.
* History of ED for ≥6 months.
* Erectile function domain of IIEF-15 score \<17.
* Documented failure to respond to PDE-5I \[definition of non-responder patients are patients with ED who don't respond to maximum dose of PDE-5I on ≥4 occasions in spite of accurate timing and good sexual stimulation\].
* Stable sexual relationship ≥ 6 months.

Exclusion Criteria:

* Penile anatomical deformities or Peyronie's disease.
* Pelvic surgery or radiation.
* Active malignancy or severe systemic illness.
* Previous penile surgery of any kind, such as penile prosthesis, penile lengthening, penile cancer surgery, penile plication or grafting.
* Contraindication to PDE5i (High risk cardiac patients, patients on nitrates, hypotension).
* Using other treatments for ED e.g., Intra-cavernoasl prostaglandin injection therapy.

Where it's running

  • Urology and Nephrology Center, Mansoura University
    Al Mansurah, Dakahlia Governorate, Egypt
    Recruiting
  • Faculty of medicine, Alexandria University
    Alexandria, Egypt
    Recruiting
  • Faculty of medicine, Aswan university
    Aswān, Egypt
    Recruiting
  • Faculty of Medicine - Assiut University
    Asyut, Egypt
    Recruiting
  • Cairo University, faculty of medicine
    Cairo, Egypt
    Recruiting
  • Faculty of medicine, Ain Shams University
    Cairo, Egypt
    Recruiting
Show 5 more locations
  • Faculty of medicine, Azhar University
    Cairo, Egypt
    Recruiting
  • Faculty of medicine, october 6 Univeristy
    Cairo, Egypt
    Recruiting
  • Faculty of medicine, Luxor university
    Luxor, Egypt
    Recruiting
  • faculty of medicine, Minya University
    Minya, Egypt
    Recruiting
  • Faculty of medicine, Tanta University
    Tanta, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.